Search research articles
Contact Us
Filters
Showing results (111-120 of 148) with videos related to
Page
of 15
Sort By:
Plos Neglected Tropical Diseases
|
June 10, 2011
Loxosceles gaucho venom-induced acute kidney injury--in vivo and in vitro studies
Rui V Lucato, Regina C R M Abdulkader, Katia C Barbaro, et al.
American Journal of Nephrology
|
December 15, 2017
Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial
Finnian R Mc Causland, Brian Claggett, Marc A Pfeffer, et al.
Journal of Critical Care
|
June 4, 2018
Use of regional citrate anticoagulation for continuous venovenous hemodialysis in critically ill cancer patients with acute kidney injury
Verônica Torres Costa E Silva, Renato Antunes Caires, Juliana Silva Bezerra, et al.
Plos One
|
March 4, 2016
Evaluation of Intermittent Hemodialysis in Critically Ill Cancer Patients with Acute Kidney Injury Using Single-Pass Batch Equipment
Verônica Torres da Costa E Silva, Elerson C Costalonga, Ana Paula Leandro Oliveira, et al.
Kidney International Reports
|
September 22, 2025
Community-Acquired Acute Kidney Injury and Late Kidney Dysfunction in Survivors of COVID-19 Hospitalization
Heitor S Ribeiro, Marcella M Frediani, Lia Marçal, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 21, 2016
C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
Finnian R Mc Causland, Brian Claggett, Emmanuel A Burdmann, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
September 15, 2025
Impact of Computed Tomography-Derived Body Composition Analysis on the Performance of GFR Estimating Equations in Patients with Cancer
Verônica T Costa E Silva, Meghan E Sise, Lesley A Inker, et al.
Circulation
|
November 23, 2011
Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience
Hicham Skali, Hans-Henrik Parving, Patrick S Parfrey, et al.
Journal of Nephrology
|
May 2, 2025
Total kidney volume as a predictor of measured glomerular filtration rate in patients with solid tumors: a prospective cross-sectional analysis
Regis Otaviano Franca Bezerra, Fernando Louzada Strufaldi, Patricia Perola Dantas, et al.
American Journal of Nephrology
|
November 3, 2025
Endothelin-1 and Cardio-Kidney Events among Patients with Chronic Kidney Disease, Diabetes, and Anemia
Finnian R Mc Causland, Brian L Claggett, Petr Jarolim, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 148) with videos related to
Sort By:
Page
of 15
Plos Neglected Tropical Diseases
|
June 10, 2011
Loxosceles gaucho venom-induced acute kidney injury--in vivo and in vitro studies
Rui V Lucato, Regina C R M Abdulkader, Katia C Barbaro, et al.
American Journal of Nephrology
|
December 15, 2017
Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial
Finnian R Mc Causland, Brian Claggett, Marc A Pfeffer, et al.
Journal of Critical Care
|
June 4, 2018
Use of regional citrate anticoagulation for continuous venovenous hemodialysis in critically ill cancer patients with acute kidney injury
Verônica Torres Costa E Silva, Renato Antunes Caires, Juliana Silva Bezerra, et al.
Plos One
|
March 4, 2016
Evaluation of Intermittent Hemodialysis in Critically Ill Cancer Patients with Acute Kidney Injury Using Single-Pass Batch Equipment
Verônica Torres da Costa E Silva, Elerson C Costalonga, Ana Paula Leandro Oliveira, et al.
Kidney International Reports
|
September 22, 2025
Community-Acquired Acute Kidney Injury and Late Kidney Dysfunction in Survivors of COVID-19 Hospitalization
Heitor S Ribeiro, Marcella M Frediani, Lia Marçal, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 21, 2016
C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
Finnian R Mc Causland, Brian Claggett, Emmanuel A Burdmann, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
September 15, 2025
Impact of Computed Tomography-Derived Body Composition Analysis on the Performance of GFR Estimating Equations in Patients with Cancer
Verônica T Costa E Silva, Meghan E Sise, Lesley A Inker, et al.
Circulation
|
November 23, 2011
Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience
Hicham Skali, Hans-Henrik Parving, Patrick S Parfrey, et al.
Journal of Nephrology
|
May 2, 2025
Total kidney volume as a predictor of measured glomerular filtration rate in patients with solid tumors: a prospective cross-sectional analysis
Regis Otaviano Franca Bezerra, Fernando Louzada Strufaldi, Patricia Perola Dantas, et al.
American Journal of Nephrology
|
November 3, 2025
Endothelin-1 and Cardio-Kidney Events among Patients with Chronic Kidney Disease, Diabetes, and Anemia
Finnian R Mc Causland, Brian L Claggett, Petr Jarolim, et al.
Page
of 15